January 25, 2016

February 6, 2015

Oregon-based drug maker James G. Cole Inc., and its president James G. Cole and former general manager Julie D. Graves, have been permanently enjoined from selling their products which are distributed under the name “Maxam Nutraceutics.” According to the government, the company’s products are unapproved, misbranded and manufactured under conditions that are inadequate to ensure their quality. The court based its decision in part on the company’s claims the products could treat autism, Alzheimer’s, HIV and Fibromyalgia, among other diseases. DOJ

*     *     *

If you would like more information or would like to speak to a member of Constantine Cannon’s whistleblower lawyer team, please click here.